Attached files

file filename
EX-3.1 - EXHIBIT 3.1 - NeuroMetrix, Inc.v233967_ex3-1.htm
EX-99.1 - EXHIBIT 99.1 - NeuroMetrix, Inc.v233967_ex99-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported):  September 1, 2011
 
NEUROMETRIX, INC.
(Exact name of registrant as specified in charter)
 
Delaware
 
001-33351
 
04-3308180
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
62 Fourth Avenue, Waltham, Massachusetts
 
02451
(Address of principal executive offices)
 
(Zip Code)
 
(781) 890-9989
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

 
Item 8.01 
Other Events.

               On September 1, 2011, NeuroMetrix, Inc. (“NeuroMetrix” or “we”) filed a Certificate of Amendment to its Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware, to effect a 1-for-6 reverse stock split of its common stock.

As previously disclosed on a Current Report on Form 8-K filed on May 16, 2011, our stockholders approved an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our common stock, at a ratio in the range of 1-for-2 to 1-for-8.  On August 30, 2011, the Board of Directors selected the 1-for-6 reverse stock split ratio and authorized the implementation of the reverse stock split.

As a result of the reverse stock split, every six shares of our pre-reverse split common stock will be combined and reclassified into one share of our common stock.  No fractional shares will be issued in connection with the reverse stock split.  Stockholders who otherwise would be entitled to receive a fractional share in connection with the reverse stock split will receive a cash payment in lieu thereof.  Our post-reverse split common stock has a new CUSIP number: 641255203, but the par value and other terms of the common stock were not affected by the reverse stock split.

The post-reverse split common stock will trade on the NASDAQ Capital Market with a “D” added, under the symbol “NUROD” for the 20 trading days beginning September 2, 2011 to designate that it is trading on a post-reverse split basis, and will resume trading under the symbol “NURO” after the 20-trading day period has expired.

Our transfer agent, American Stock Transfer & Trust Company, LLC, is acting as exchange agent for the reverse stock split and will send instructions to stockholders of record regarding the exchange of certificates for common stock.

On September 1, 2011, we also issued a press release with respect to the reverse stock split described above.

A copy of the Certificate of Amendment to our Restated Certificate of Incorporation, as amended, is being filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.  A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 

 
 

 
 
 
Item 9.01 
Financial Statements and Exhibits.
 
 
(d) 
Exhibits
 
Exhibit Number
 
Description
     
3.1
 
Certificate of Amendment to Restated Certificate of Incorporation of NeuroMetrix, Inc., dated September 1, 2011.
     
99.1
 
Press release dated September 1, 2011.
     
 
 
 
 
 
 

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
   
NEUROMETRIX, INC.
 
       
       
Date: September 1, 2011
/s/
THOMAS T. HIGGINS
 
   
Thomas T. Higgins
 
   
Senior Vice President, Chief Financial Officer and Treasurer
 
 

 
 
 

 

 
EXHIBIT INDEX
 
Exhibit Number
 
Description
     
3.1
 
Certificate of Amendment to Restated Certificate of Incorporation of NeuroMetrix, Inc., dated September 1, 2011.
     
99.1
 
Press release dated September 1, 2011.